Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation

European Journal of Pharmacology

Volumn 401, Issue 3, 2000, Pages 349-356

  Calapai, Gioacchino ^a   Marciano, Maria C ^a   Corica, Francesco ^b   Allegra, Alessandro ^b   Parisi, Alessandra ^a   Frisina, Nicola ^b   Caputi, Achille P ^a   Buemi, Michele ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Brain injury; Cerebral ischemia; Erythropoietin; Neuronal death delayed; Nitric oxide (NO)

Indexed keywords

ERYTHROPOIETIN; MALONALDEHYDE; NITRIC OXIDE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; GERBIL; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ALDEHYDES; ANIMALS; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; ERYTHROPOIETIN; GERBILLINAE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; NITRATES; NITRIC OXIDE; NITRITES; RECOMBINANT PROTEINS; SURVIVAL RATE;

EID: 0034637297     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00466-0     Document Type: Article

References (40)

1. Allegra A., Galasso A., Siracusano L., Aloisi C., Corica F., Laganà A., Frisina N., Buemi M. Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock. Nephron. 74:1996;431-432.
2. Allegra V., Mengozzi G., Martimbianco L., Vasile A. Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients. Am. J. Nephrol. 16:1996;304-308.
3. Andrew P.J., Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 15:1999;521-531.
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide an superoxide. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1620-1624.
5. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19:1999;643-651.
6. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radical Res. 31:1999;577-596.
7. Buemi M., Allegra A., Aloisi C., Frisina N. Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialyzed subjects. Am. J. Nephrol. 11:1991;281-283.
8. Buemi M., Denuzzo G., Allegra A., Aloisi C., Squadrito F., Squadrito G., Dattola A., Corica F., Vermiglio G. Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine. Int. J. Microcirc. 15:1995;283-286.
9. Buemi M., Allegra A., Corica F., Floccari F., D'Avella D., Aloisi C., Calapai G., Iacopino G., Frisina N. Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrol., Dial., Transplant. 15:2000;422-423.
10. Buemi M., Grasso G., Corica F., Calapai G., Maria Salpietro F., Casuscelli T., Sfacteria A., Aloisi C., Concetta A., Sturiale A., Frisina N., Tomasello F. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur. J. Pharmacol. 392:2000;31-34.
11. Calapai G., Squadrito F., Rizzo A., Crisafulli C., Campo G.M., Marciano M.C., Mazzaglia G., Caputi A.P. IRFI-016, a new antioxidant drug, limits brain damage induced by transient cerebral ischaemia. Drugs Exp. Clin. Res. 19:1993;159-164.
12. Calapai G., Squadrito F., Rizzo A., Marciano M.C., Campo G.M., Caputi A.P. Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;209-215.
13. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92:1996;3717-3720.
14. Eschbach J.W., Kelly M.R., Haley N.R., Abels R.I., Adamson J.W. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N. Engl. J. Med. 321:1989;158-163.
15. Fellner S.K., Lang R.M., Neumann A., Korcarz C., Borow K.M. Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin. Kidney Int. 44:1993;1309-1315.
16. Goodnough L.T., Monk T.G., Andriole G.L. Current concepts: erythropoietin therapy. N. Engl. J. Med. 336:1997;933-938.
17. Hall E.D. Brain attack: acute therapeutic interventions; free radical scavengers and antioxidants. Neurosurg. Clin. N. Am. 8:1997;195-206.
18. Horina J.H., Fazekas F., Niederkorn K., Payer F., Valetitsch H., Winkler H.M., Horner S., Freidl W., Pogglitsch H., Krejs G.J. Cerebral hemodynamics changes following treatment with erythropoietin. Nephron. 58:1991;407-412.
19. Iadecola C. Bright and dark sides of nitric oxide in sichemic brain damage. Trends Neurosci. 20:1997;132-139.
20. Iadecola C., Ross M.E. Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann. N. Y. Acad. Sci. 19:1997;203-217.
21. Kokot F., Wiecek A., Grzesczak W., Klepacka J., Klin M., Lao M. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients. Contrib. Nephrol. 76:1989;257-270.
22. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., Kato Y. Effects of erythropoietin on neuronal activity. J. Neurochem. 72:1999;2565-2572.
23. Lazzarino G., Vagnozzi R., Tavazzi B., Pastore F.S., Di Pierro D., Siragusa P., Belli A., Giuffrè R., Giardina B. MDA, oxypurines, and nucleosides relate to reperfusion in short-term incomplete cerebral ischemia in the rat. Free Radical Biol. Med. 13:1992;489-498.
24. Li Y., Juul S.E., Morris-Wiman J.A., Calhoun D.A., Christensen R.D. Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses. Pediatr. Res. 40:1996;376-380.
25. Lin S.Z., Chiou A.L., Wang Y. Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke. 27:1996;747-752.
26. Malinski T., Bailey F., Zhang Z.G., Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13:1993;355-358.
27. Marti H.H., Gassmann M., Wenger R.H., Kvietikova I., Morganti-Kossmann M.C., Kossmann T., Trentz O., Bauer C. Detection of erythropoietin in human cerebrospinal fluid: intrinsic erythropoietin production in the brain. Kidney Int. 51:1997;416-418.
28. Mayer B., Andrew P. Nitric oxide synthases: catalytic function and progress towards selective inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;127-133.
29. Mendelow A.D., Teasdale G.M. Pathophysiology of head injuries. Br. J. Surg. 70:1983;641-650.
30. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
31. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
32. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A. 95:1998;4635-4640.
33. Salter M., Duffy C., Garthwaite J., Strijbos P.J. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J. Neurochem. 66:1996;1683-1690.
34. Szabo C., Southan G.J., Wood E., Thiemermann C., Vane J.R. Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor. Br. J. Pharmacol. 112:1994;355-356.
35. Takemasa A., Yorioka N., Yamakido M. Investigation of the influenza-like symptoms associated with recombinant human erythropoietin therapy. J. Int. Med. Res. 25:1997;127-134.
36. Thiessen D., Yahr P. A Stereo-Taxic Brain Atlas of the Gerbil. 1977;138 University of Texas, Austin, TX.
37. Velisek L., Veliskova J., Moshe S.L. Site-specific effects of local pH changes in the substantia nigra pars reticulata on flurothyl-induced seizures. Brain Res. 782:1998;310-313.
38. Wahl M., Whalley E.T., Unterberg A., Schilling L., Parsons A.A., Baethmann A., Young A.R. Vasomotor and permeability effects of bradykinin in the cerebral microcirculation. Immunopharmacology. 33:1996;257-263.
39. White B.C., Grossman L.I., O'Neil B.J., DeGracia D.J., Neumar R.W., Rafols J.A., Krause G.S. Global brain ischemia and reperfusion. Ann. Emerg. Med. 27:1996;588-594.
40. Yamaji R., Okada T., Moriya M., Naito M., Tauruo T., Miyatake K., Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 239:1996;494-500.